Optimizing Antibody-Drug Conjugates With Computational Modelling

Optimizing antibody-drug conjugates with computational modelling

Accelerating Antibody Drug Discovery Through Computational Modeling

The Antibody Society

What are Antibody Drug Conjugates (ADCs)?

Antibody-drug Conjugates in the Clinic:

Optimize your Antibody Drug Conjugates with Shielded Linkers. Create Happy ADC’s!

Vector Laboratories Inc

Simple and effective tools for antibody-drug conjugate screening and characterization

Optimize your Antibody Drug Conjugates with Shielded Linkers. Create Happy ADC’s!

Vector Laboratories Inc

Computational Antibody Discovery Symposium: Ben Holland (CTO, Antiverse)

The Antibody Society

Harnessing Genetic Algorithms for Optimization

TechInsightsExplorés

Biopharmaceutical Informatics Symposium - Dr. Konrad Krawczyk, Natural Antibody

The Antibody Society

The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma

Touch Medical Media

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

Model Informed Drug Development Approaches for Immunogenicity Assessments Workshop

U.S. Food and Drug Administration

Computational Antibody Discovery Symposium: Panel discussion summary

The Antibody Society

Antibody-drug Conjugate-Precision Targeted Therapy - Creative Biolabs

Creative Biolabs

Model-Based Strategy to Guide the Choice of Clinical Doses for Antibody–drug conjugates

Elsevier for Life Sciences

Antibody Drug Development Summit, Autumn 2021 - Greg Christianson introduction

The Jackson Laboratory

Challenges and Advances in Antibody-Drug Conjugates.

BioPharma Nexus Conference

Multi-objective engineering of therapeutic antibodies

ML for protein engineering seminar series

Jens Meiler - Computational Structure Prediction and Therapeutic Design with Rosetta.

Bioinformatics Seminar Series at Purdue CS